AbsEn.i
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « treatment »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
treating < treatment < treatments  Facettes :

List of bibliographic references indexed by treatment

Number of relevant bibliographic references: 945.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000002 (2021) Fabricio Souza Neves [Brésil]Correlation of the rise and fall in COVID-19 cases with the social isolation index and early outpatient treatment with hydroxychloroquine and chloroquine in the state of Santa Catarina, southern Brazil: A retrospective analysis.
000009 (2021) Rashed Noor [Bangladesh]Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic.
000011 (2021) Matthieu Million [France] ; Audrey Giraud-Gatineau [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Philippe Gautret [France] ; Didier Raoult [France]Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin.
000015 (2021) Roberto Ariel Abelda O Zu Iga [Mexique] ; Silvia Mercedes Coca [Mexique] ; Giuliana Florencia Abelda O [Mexique] ; Ruth Ana María González-Villoria [Mexique]Clinical effectiveness of drugs in hospitalized patients with COVID-19: a systematic review and meta-analysis.
000018 (2021) Amaya García-Fernández [Espagne] ; Pablo Ramos-Ruiz [Espagne] ; Alicia Ibá Ez-Criado [Espagne] ; Scar Moreno-Pérez [Espagne] ; Cristina Cambra-Poveda [Espagne] ; Juan Gabriel Martínez-Martínez [Espagne][Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients].
000022 (2021) E. Díaz [Espagne] ; R. Amézaga Menéndez [Espagne] ; P. Vidal Cortés [Espagne] ; M G Escapa [Espagne] ; B. Suberviola [Espagne] ; A. Serrano Lázaro [Espagne] ; P. Marcos Neira [Espagne] ; M. Quintana Díaz [Espagne] ; M. Catalán González [Espagne][Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)].
000024 (2021) A L Myasnikov ; S A Berns ; P A Talyzin ; F I Ershov[Interferon gamma in the treatment of patients with moderate COVID-19].
000025 (2021) Francisco Tejada Cifuentes [Espagne] ; Ángeles Lloret Callejo [Espagne] ; María José Tirado Peláez [Espagne] ; Olga Rubio Pulido [Espagne] ; Marta Ruiz-Morote Arag N [Espagne] ; Rocío Fernández Urrusuno [Espagne] ; María Isabel Mu Oz Carreras [Espagne] ; María Isabel Méndez Esteban [Espagne] ; Victoria Maestre Sánchez [Espagne] ; Antonio García Bonilla [Espagne] ; José Manuel Paredero Dominguez [Espagne] ; Virginia Arroyo Pineda [Espagne] ; Esther Marco Tej N [Espagne] ; Gregorio Romero Candel [Espagne] ; Ana Isabel Fernández Marchante [Espagne] ; José Marco Del Rio [Espagne] ; Teresa Ortiz Martín [Espagne] ; Piedad L Pez Sánchez [Espagne][Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine].
000026 (2021) M. Bovet [Allemagne] ; D. Wadsack [Allemagne] ; F. Kosely [Allemagne] ; W. Zink [Allemagne] ; R. Zahn [Allemagne][Fatal course of COVID-19 despite IL-6 receptor blockade in cytokine storm : Perimyocarditis and coagulopathy after administration of tocilizumab].
000031 (2021) Hülya Gamze Çelik [Turquie] ; Iran Keske [Turquie] ; Ülker Ener [Turquie] ; Müge Tekba [Turquie] ; Mahir Kapmaz [Turquie] ; Krü Taylan Ahin [Turquie] ; Asl Özy Ld R M [Turquie] ; Saide Aytekin [Turquie] ; Vedat Aytekin [Turquie] ; Önder Ergönül [Turquie]Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?
000032 (2021) Yesim Oymak ; Tuba H. Karapinar ; Lker Devrim [Turquie]Why G6PD Deficiency Should Be Screened Before COVID-19 Treatment With Hydroxychloroquine?
000033 (2021) Dania Altulea [Pays-Bas] ; Sjors Maassen [Pays-Bas] ; Maksim V. Baranov [Pays-Bas] ; Geert Van Den Bogaart [Pays-Bas]What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.
000035 (2021) L. Anedda [Italie] ; L. Bianchini ; L. Cuzzolin ; G. Finco ; V. Fanos ; M A MarcialisWhat if COVID-19 affects the child: which weapons and how to use them.
000037 (2021) Isabel Fambuena-Muedra [Espagne] ; Marta Jiménez-García [Belgique] ; Sarah Hershko [Belgique] ; Irene Altemir-G Mez [Espagne] ; Ana Tobarra-L Pez [Espagne]What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects.
000042 (2021) Amaya García-Fernández [Espagne] ; Pablo Ramos-Ruiz [Espagne] ; Alicia Ibá Ez-Criado [Espagne] ; Scar Moreno-Pérez [Espagne] ; Cristina Cambra-Poveda [Espagne] ; Juan Gabriel Martínez-Martínez [Espagne]Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.
000046 (2021) Paulo Roberto Bignardi [Brésil] ; Carolina Santos Vengrus [Brésil] ; Bruno Matos Aquino [Brésil] ; Alcindo Cerci Neto [Brésil]Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials.
000049 (2021) Boghuma K. Titanji [États-Unis] ; Monica M. Farley [États-Unis] ; Ashish Mehta [États-Unis] ; Randi Connor-Schuler [États-Unis] ; Abeer Moanna [États-Unis] ; Sushma K. Cribbs [États-Unis] ; Jesse O'Shea [États-Unis] ; Kathryn Desilva [États-Unis] ; Bonnie Chan [États-Unis] ; Alex Edwards [États-Unis] ; Christina Gavegnano [États-Unis] ; Raymond F. Schinazi [États-Unis] ; Vincent C. Marconi [États-Unis]Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019.
000050 (2021) Isabel S. Hernandes [Brésil] ; Haroldo C. Da Silva [Brésil] ; Hélio F. Dos Santos [Brésil] ; Wagner B. De Almeida [Brésil]Unveiling the Molecular Structure of Antimalarial Drugs Chloroquine and Hydroxychloroquine in Solution through Analysis of 1H NMR Chemical Shifts.
000056 (2021) Jessica S C. Leung [Hong Kong] ; Maurice M W. Cheng [Nouvelle-Zélande]Trust in the time of corona: epistemic practice beyond hard evidence.
000059 (2021) Katryna A. Gouin [États-Unis] ; Stephen Creasy [États-Unis] ; Mary Beckerson [États-Unis] ; Martha Wdowicki [États-Unis] ; Lauri A. Hicks [États-Unis] ; Jennifer N. Lind [États-Unis] ; Andrew I. Geller [États-Unis] ; Daniel S. Budnitz [États-Unis] ; Sarah Kabbani [États-Unis]Trends in Prescribing of Antibiotics and Drugs Investigated for COVID-19 Treatment in U.S. Nursing Home Residents During the COVID-19 Pandemic.
000060 (2021) Diana Laila Ramatillah [Indonésie] ; Suri Isnaini [Indonésie]Treatment profiles and clinical outcomes of COVID-19 patients at private hospital in Jakarta.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "treatment" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "treatment" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    treatment
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021